Solving Kids' Cancer UK is a highly targeted, collaborative funder focused almost exclusively on improving outcomes for children with neuroblastoma, especially relapsed, refractory, indolent, and high-risk disease. It supports both translational science and patient-benefit initiatives, often by convening international consortia and co-funding competitive research calls with other childhood cancer charities. Its grants are typically designed to move promising pre-clinical discoveries into clinical trials or improve support for affected families in the UK.
Competitive, invitation-based RFA model with no unsolicited proposals; funds are usually awarded through time-limited calls, often co-funded with partner charities, with grant sizes ranging from smaller UK projects (up to £60,000 over two years) to larger international translational awards (up to £250,000 per project or pooled funds in the £500,000-$2 million range).
Sign up free to see how well your nonprofit fits this funder, get an AI-generated pitch, and unlock similar foundations.
Watch for annual RFAs, typically issued in September, and apply only through the specific call process since unsolicited proposals are not accepted. Eligibility is usually tied to neuroblastoma-focused, patient-benefit research, often with strong translational or trial-enabling relevance; international collaboration is common, and deadlines can be strict (for example, the BEACON2 2025 RFA deadline is 16 February 2026 at 12:00 GMT).
Current and upcoming funding from Solving Kids' Cancer UK that your nonprofit may be able to apply for.
Who can apply: Varies by individual RFA; requirements published within each RFA (may include patient group focus, intervention type, geographical footprint).
Track these deadlines, get reminders, and see how well your nonprofit fits — free with a Kindora account.
Create a free accountDeadlines and eligibility are summarized from public sources and may change — always confirm the details on the funder's official application page before applying.